imjudo
Imjudo (Tremelimumab-Actl) is a medication used to treat Hepatocellular Carcinoma.
Tremelimumab-Actl · by Astrazeneca Ab
Key facts
- Active ingredient
- Tremelimumab-Actl
- Form
- Injectable
- Strength
- TREMELIMUMAB-ACTL 25MG/1.25ML(20MG/ML) · TREMELIMUMAB-ACTL 300MG/15ML(20MG/ML)
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- hepatocellular carcinoma
- Manufacturer
- Astrazeneca Ab
- FDA application
- BLA761270
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Imjudo treat?
- Imjudo (Tremelimumab-Actl) may be used to treat hepatocellular carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Imjudo?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Imjudo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Imjudo?
- Imjudo is marketed by Astrazeneca Ab. You can see Astrazeneca Ab's full profile, rating, and other products on pharmaranks.
- Is Imjudo a brand-name or generic drug?
- Imjudo is a brand-name product with the active ingredient Tremelimumab-Actl.
- Is Imjudo available over the counter?
- No. Imjudo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Imjudo come in?
- Imjudo is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Imjudo FDA-registered?
- Imjudo is on record with the U.S. FDA under application number BLA761270. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about TREMELIMUMAB-ACTL
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming TREMELIMUMAB-ACTL — the active ingredient in Imjudo, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- angina pectoris1 reports
- cough1 reports
- drug-induced liver injury1 reports
- immune-mediated enterocolitis1 reports
- international normalised ratio increased1 reports
Read these as a signal, not a rate. A report does not mean TREMELIMUMAB-ACTL caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
tecentriq
Atezolizumab
nexavar
Sorafenib Tosylate
pegasys
Peginterferon Alfa-2a
pegintron
Peginterferon Alfa-2b
sorafenib tosylate
Sorafenib Tosylate
stivarga
Regorafenib
Compare Imjudo head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
imjudo
New